Bio-Rad Laboratories has reached an agreement to acquire US-based biotechnology company RainDance Technologies in order to expand into next-generation sequencing applications and foster its position in Droplet Digital PCR.
Also based in the US, the acquirer company provides life science research and clinical diagnostic products.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
US-based healthcare company Eli Lilly and Company is set to acquire CoLucid Pharmaceuticals for up to $960m in a tender offer representing a consideration of $46.5 a share.
CoLucid is a biopharmaceutical company also based in the US.